explore -WSS

explore

author：entertainment 2025-10-01 05:39:32 - browse：3248

Boxes of Ozempic photo illustration. -- health coverage from STAT — Mario Tama/Getty Images

LONDON — Novo Nordisk’s diabetes medication Ozempic cut the risk of patients developing advanced kidney disease or dying from kidney or heart complications, the company said Tuesday, adding to the evidence the wildly popular drug has broader health benefits for patients beyond addressing their diabetes.

Overall, Ozempic lowered the risk of progression of patients’ kidney disease and of related health events by 24% versus placebo, according to the topline results. The company, which will present full data from the study later this year, said it would file for an expanded approval of Ozempic based on the data in both the U.S. and Europe.

The positive announcement had been expected since October, when Novo announced it was ending the FLOW trial early because an interim data analysis showed the drug was surpassing the study’s goals. Still, the results provide an important data point for Novo both as its medicines face increasing competition and as it tries to get more insurers to cover its related obesity drug Wegovy.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： George Santos makes 1st court appearance after pleading not guilty to 13 counts
Next article： Adults seen as increasingly susceptible to measles

WSS

First medicine developed to treat MASH expected to be approved soon

National panel will explore requiring free Covid tests

National panel will explore requiring free Covid tests

What to expect as Trump is arraigned on his Jan 6. indictment

NIH launches clinical trials and new research office for long Covid

Sen. Paul opposes bill to ban Chinese biotechs

leisure time

explore

knowledge

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

What the airline industry can learn from medicine

Jerome Adams on the need for new antivirals for Covid

The Readout: Amylyx, Alumis, and Lundbeck drug updates

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Mitch McConnell episode has important public health takeaway

23andMe had bad news about my health. I wish a person had delivered it

New safety details link Apellis eye drug to rare cases of blindness

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Mitch McConnell episode has important public health takeaway

Wikipedia

Mitch McConnell episode has important public health takeaway

IVF, abortion rights issues kick off Biden’s State of the Union

Just how do doctors, lawmakers, and the public define abortion?

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

Amylyx ALS drug fails large clinical trial

What to expect as Trump is arraigned on his Jan 6. indictment

focus

leisure time

focus

entertainment